Severity scores for predicting clinically relevant outcomes for immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia;Índices predictores de eventos adversos en el adulto inmunocompetente hospitalizado por neumonía neumocóccica adquirida en la comunidad

Revista Chilena de Infectologia

Volumn 28, Issue 4, 2011, Pages 303-309

  Fernando Saldías, Peñafiel ^a   Orlando Diaz P ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Community acquired pneumonia; Mortality; Prediction rule; Risk classification; Severity assessment; Streptococcus pneumoniae

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; COMMUNICABLE DISEASE; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOCOMPETENCE; INTENSIVE CARE; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; STREPTOCOCCUS PNEUMONIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IMMUNOCOMPETENCE; INTENSIVE CARE; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PROGNOSIS; RESPIRATION, ARTIFICIAL; YOUNG ADULT;

EID: 80052883764     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-10182011000500001     Document Type: Article

References (33)

1. Norby S R, Pope K A. Pneumococcal pneumonia. J Infect 1979; 1: 109-20.
2. Afessa B, Greaves W L, Frederick W R. Pneumococcal bacteremia in adults: a 14-year experience in an inner-city university hospital. Clin Infect Dis 1995; 21: 345-51.
3. Fine M J, Smith M A, Carson C A, Mutha S S, Sankey S S, Weissfeld L A, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275: 134-41.
4. Burman L A, Norrby R, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 1985; 7: 133-42.
5. Ortqvist A, Grepe A, Julander I, Kalin M. Bacteremic pneumococcal pneumonia in Sweden: clinical course and outcome and comparison with non-bacteremic pneumococcal and mycoplasmal pneumonias. Scand J Infect Dis 1988; 20: 163-71.
6. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60: 759-76.
7. Frei C R, Restrepo M I, Mortensen E M, Burgess DS. Impact of guideline-concordant empiric antibiotic therapy in communityacquired pneumonia. Am J Med 2006; 119: 865-71.
8. Reyes S, Martínez R, Cremades M J, Martínez E, Soler J J, Menéndez R. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission. Respir Med 2007;101: 1909-15.
9. Martínez R, Reyes S, Lorenzo M J, Menéndez R. Impact of guidelines on outcome: the evidence. Semin Respir Crit Care Med 2009; 30: 172-8.
10. Mandell L A, Wunderink R G, Anzueto A, Bartlett J G, Campbell G D, Dean N C, et al. Infectious Diseases Society of America/ American Thoracic Society Consensus Guidelines on the management of communityacquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl 2): S27-S72.
11. Lim W S, Baudouin S V, George R C, Hill A T, Jamieson C, Le Jeune I, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. The British Thoracic Society Guidelines for the management of communityacquired pneumonia in adults: update 2009. Thorax 2009; 64 (Suppl 3):1-55.
12. Saldías F, Pavié J. Consenso Chileno de Neumonía Comunitaria. Evaluación de la gravedad en la neumonía del adulto adquirida en la comunidad. Rev Chil Infectol 2005; 22 (Supl 1): S39-S45.
13. Fine M J, Auble T E, Yealy D M, Hanusa B H, Weissfeld L A, Singer D E, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50.
14. Lim W S, Van Der Eerden M M, Laing R, Boersma W G, Karalus N, Town G I, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-82.
15. España P P, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 2006; 174: 1249-56.
16. Fang G D, Fine M, Orloff J, Arisumi D, Yu V L, Kapoor W, et al. New emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1990; 69: 307-16.
17. Bauer T T, Ewig S, Marre R, Suttorp N, Welte T; The CAPNETZ Study Group. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006; 260: 93-101.
18. th informational supplement. CLSI document M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
19. Niederman M S. Making sense of scoring systems in community acquired pneumonia. Respirology 2009; 14: 327-35.
20. Fine M J, Hough L J, Medsger A R, Li Y H, Ricci E M, Singer D E, et al. The hospital admission decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 1997; 157: 36-44.
21. Neill A M, Martin I R, Weir R, Anderson R, Chereshsky A, Epton M J, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996; 51: 1010-6.
22. Díaz A, Torres C, Flores L J, García P, Saldías F. Community acquired pneumococcal pneumonia in hospitalized adult patients. Rev Med Chile 2003; 131: 505-14.
23. Frankel R E, Virata M, Hardalo C, Altice F L, Friedland G. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis 1996; 23: 577-84.
24. Noriega L M, González P, Canals C, Michaud P. Septicemia por Streptococcus pneumoniae. Análisis de 40 casos. Rev Med Chile 1994; 122: 1385-92.
25. Rioseco M L, Riquelme R. Neumonía neumocócica bacterémica en 45 adultos inmunocompetentes hospitalizados. Cuadro clínico y factores pronósticos. Rev Med Chile 2004; 132: 588-94.
26. Mella S, Blamey R, Paiva O, Yáñez J, Riedel G, Aylwin M, et al. Impacto de la evaluación infectológica en el uso racional de antimicrobianos en pacientes con bacteriemia por Streptococcus pneumoniae. Rev Chil Infectol 2007; 24: 264-9.
27. Bordón J, Peyrani P, Brock G N, Blasi F, Rello J, File T, et al; CAPO Study Group. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest 2008; 133: 618-24.
28. Brandenburg J A, Marrie T J, Coley C M, Singer D E, Obrosky D S, Kapoor W N, et al. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia. J Gen Intern Med 2000; 15: 638-46.
29. Capelastegui A, España P P, Quintana J M, Areitio I, Gorordo I, Egurrola M, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006; 27: 151-7.
30. Man S Y, Lee N, Ip M, Antonio G E, Chau S S, Mak P, et al. Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 2007; 62: 348-53.
31. España P P, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, et al. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia. Chest 2009; 135: 1572-9.
32. Buising K L, Thursky K A, Black J F, MacGregor L, Street A C, Kennedy M P, et al. A prospective comparison of severity scores for identifying patients with severe communityacquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax 2006; 61: 419-24.
33. Myint P K, Kamath A V, Vowler S L, Maisey D N, Harrison B D. The CURB (confusion, urea, respiratory rate and blood pressure) criteria in community-acquired pneumonia (CAP) in hospitalised elderly patients age 65 years and over: a prospective observational cohort study. Age Ageing 2005; 34: 75-7.